These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 39120840)
1. Clipped Axillary Node as a Potential Surrogate for Overall Axillary Nodal Status in Inflammatory Breast Cancer Patients after Neoadjuvant Chemotherapy. Lohani KR; Hoskin TL; Yasir S; Olson CA; Boughey JC; Hieken TJ; Degnim AC Ann Surg Oncol; 2024 Oct; 31(11):7431-7440. PubMed ID: 39120840 [TBL] [Abstract][Full Text] [Related]
2. Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) : A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment. Siso C; de Torres J; Esgueva-Colmenarejo A; Espinosa-Bravo M; Rus N; Cordoba O; Rodriguez R; Peg V; Rubio IT Ann Surg Oncol; 2018 Mar; 25(3):784-791. PubMed ID: 29197044 [TBL] [Abstract][Full Text] [Related]
3. Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance). Boughey JC; Ballman KV; Le-Petross HT; McCall LM; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Feliberti EC; Hunt KK Ann Surg; 2016 Apr; 263(4):802-7. PubMed ID: 26649589 [TBL] [Abstract][Full Text] [Related]
4. Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Switalla KM; Boughey JC; Dimitroff K; Yau C; Ladores V; Yu H; Tchou J; Golshan M; Ahrendt G; Postlewait LM; Piltin M; Reyna CR; Matsen CB; Tuttle TM; Wallace AM; Arciero CA; Lee MC; Tseng J; Son J; Rao R; Sauder C; Naik A; Howard-McNatt M; Lancaster R; Norwood P; Esserman LJ; Mukhtar RA Ann Surg Oncol; 2024 Oct; 31(11):7249-7259. PubMed ID: 38995451 [TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Newman EA; Sabel MS; Nees AV; Schott A; Diehl KM; Cimmino VM; Chang AE; Kleer C; Hayes DF; Newman LA Ann Surg Oncol; 2007 Oct; 14(10):2946-52. PubMed ID: 17514407 [TBL] [Abstract][Full Text] [Related]
6. Surgical Management of the Axilla in Clinically Node-Positive Patients Receiving Neoadjuvant Chemotherapy: A National Cancer Database Analysis. Wong SM; Weiss A; Mittendorf EA; King TA; Golshan M Ann Surg Oncol; 2019 Oct; 26(11):3517-3525. PubMed ID: 31342389 [TBL] [Abstract][Full Text] [Related]
7. Improved False-Negative Rates with Intraoperative Identification of Clipped Nodes in Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy. Cabıoğlu N; Karanlık H; Kangal D; Özkurt E; Öner G; Sezen F; Yılmaz R; Tükenmez M; Önder S; İğci A; Özmen V; Dinççağ A; Engin G; Müslümanoğlu M Ann Surg Oncol; 2018 Oct; 25(10):3030-3036. PubMed ID: 29978371 [TBL] [Abstract][Full Text] [Related]
8. ASO Author Reflections: Time to Explore Minimally Invasive Axillary Nodal Staging After Neo-Adjuvant Chemotherapy in Inflammatory Breast Cancer. Lohani KR; Hoskin TL; Yasir S; Olson CA; Boughey JC; Hieken TJ; Degnim AC Ann Surg Oncol; 2024 Oct; 31(11):7441-7442. PubMed ID: 39068307 [TBL] [Abstract][Full Text] [Related]
9. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy? Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791 [TBL] [Abstract][Full Text] [Related]
10. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Kuehn T; Bauerfeind I; Fehm T; Fleige B; Hausschild M; Helms G; Lebeau A; Liedtke C; von Minckwitz G; Nekljudova V; Schmatloch S; Schrenk P; Staebler A; Untch M Lancet Oncol; 2013 Jun; 14(7):609-18. PubMed ID: 23683750 [TBL] [Abstract][Full Text] [Related]
11. Feasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients Before Neoadjuvant Chemotherapy: A Preliminary Study. Kim EY; Byon WS; Lee KH; Yun JS; Park YL; Park CH; Youn IY; Choi SH; Choi YJ; Kook SH; Do SI World J Surg; 2018 Feb; 42(2):582-589. PubMed ID: 28808843 [TBL] [Abstract][Full Text] [Related]
12. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. Caudle AS; Yang WT; Krishnamurthy S; Mittendorf EA; Black DM; Gilcrease MZ; Bedrosian I; Hobbs BP; DeSnyder SM; Hwang RF; Adrada BE; Shaitelman SF; Chavez-MacGregor M; Smith BD; Candelaria RP; Babiera GV; Dogan BE; Santiago L; Hunt KK; Kuerer HM J Clin Oncol; 2016 Apr; 34(10):1072-8. PubMed ID: 26811528 [TBL] [Abstract][Full Text] [Related]
13. Feasibility of targeted axillary dissection for de-escalation of surgical treatment after neoadjuvant chemotherapy in breast cancer. Aragón-Sánchez S; Ciruelos-Gil E; López-Marín L; Galindo A; Tabuenca-Mateos MJ; Jiménez-Arranz S; Colmenero-Hernández M; Oliver-Pérez MR Surg Oncol; 2022 Sep; 44():101823. PubMed ID: 36041377 [TBL] [Abstract][Full Text] [Related]
14. Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis. Srour MK; Tseng J; Luu M; Alban RF; Giuliano AE; Chung A Ann Surg Oncol; 2019 Oct; 26(10):3305-3311. PubMed ID: 31342364 [TBL] [Abstract][Full Text] [Related]
15. Prediction of axillary response by monitoring with ultrasound and MRI during and after neoadjuvant chemotherapy in breast cancer patients. Eun NL; Son EJ; Gweon HM; Kim JA; Youk JH Eur Radiol; 2020 Mar; 30(3):1460-1469. PubMed ID: 31802216 [TBL] [Abstract][Full Text] [Related]
16. Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy. Cabıoğlu N; Karanlık H; Yılmaz R; Emiroğlu S; Tükenmez M; Bademler S; Şimşek DH; Kantarcı TR; Yirgin İK; Bayram A; Dursun M World J Surg Oncol; 2024 Jul; 22(1):178. PubMed ID: 38971793 [TBL] [Abstract][Full Text] [Related]
17. Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study. Morency D; Dumitra S; Parvez E; Martel K; Basik M; Robidoux A; Poirier B; Holloway CMB; Gaboury L; Sideris L; Meterissian S; Boileau JF Ann Surg Oncol; 2019 Dec; 26(13):4337-4345. PubMed ID: 31605348 [TBL] [Abstract][Full Text] [Related]
18. Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy? Montagna G; Lee MK; Sevilimedu V; Barrio AV; Morrow M Ann Surg Oncol; 2022 Oct; 29(10):6133-6139. PubMed ID: 35902495 [TBL] [Abstract][Full Text] [Related]
19. Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes at Targeted Axillary Dissection. Moore AM; Caudle AS; Sun SX; Yi M; Smith BD; Valero V; Yang W; Kuerer HM; Hunt KK; Teshome M Ann Surg Oncol; 2024 Oct; 31(11):7264-7270. PubMed ID: 39044106 [TBL] [Abstract][Full Text] [Related]
20. Intraoperative Touch Imprint Cytology in Targeted Axillary Dissection After Neoadjuvant Chemotherapy for Breast Cancer Patients with Initial Axillary Metastasis. Wu S; Wang Y; Zhang N; Li J; Xu X; Shen J; Liu G Ann Surg Oncol; 2018 Oct; 25(11):3150-3157. PubMed ID: 30083833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]